Hep AD38 Assay
Approximately 5% of the world’s population has been infected with hepatitis B virus (HBV). Ten percent of these adults will become chronic carriers, as will 95% of the infants infected perinatally. Those that do become chronically infected with HBV are at increased risk of developing liver dysfunction, cirrhosis, and liver failure (1). In addition, they also have a greater incidence of heptocellular carcinoma (2). Approximately two million chronic carriers die annually from liver disease attributed to infection by HBV (3).
KeywordsHepatitis EDTA Tyrosine Citrate Penicillin
- 2.Beasley, R. P. and Hwang, L.-Y. (1994) Epidemiology of heptocellular carcinoma, in Viral Hepatitis and Liver Disease (Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H., eds.), Grune & Stratton, New York, pp. 209–224.Google Scholar
- 3.World Health Organization (1990) WHO reports decry of neglect of world health problems. ASM News 56, 358,359.Google Scholar
- 4.Seeger, C., Summers, J., and Mason, W. S. (1991) Viral DNA synthesis, in Current Topics in Microbiology and Immunology, vol. 168. Springer-Verlag, Berlin,pp. 41–66.Google Scholar
- 9.Ladner, S. K., Otto, M. J., Barker, C. S., Zaifert, K., Wang, G.-H., Guo, J.-T., Seeger, C., and King, R. W. (1997) Inducible expression of human hepatitis B virus in stably transfected hepatoblastoma cell: a novel system for screening potential inhibitors of HBV replication, submitted for publication.Google Scholar
- 10.Current Protocols in Molecular Biology, vol. 3 (1995) (Janssen, K., series ed.), Wiley, New York, pp. A.2.5.Google Scholar